Entyvio for Kid IBD; Phase III Win in PFIC; Drug Flops for Eosinophilic Esophagitis
Vedolizumab (Entyvio) was both safe and effective at inducing clinical remission for kids…
Browsing Tag
eosinophilic
Gamechanger: New way to improve outcomes in kids with eosinophilic esophagitis: New…
A groundbreaking study from Ann & Robert H. Lurie Children's Hospital of Chicago determined the threshold for a new measure of early scarring in the esophagus of children with…
FDA Approves First Treatment for Eosinophilic Esophagitis
Physician’s Briefing Staff
WEDNESDAY, May 25, 2022 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) approved the monoclonal antibody…
First Treatment Approved for Eosinophilic Esophagitis
Dupilumab (Dupixent) became the first drug approved to treat eosinophilic esophagitis in adults…
Dupilumab Continues to Show Promise in Eosinophilic Esophagitis
PHOENIX -- Nearly three-fifths of patients with eosinophilic esophagitis (EoE) achieved remission after treatment with dupilumab…
Allakos Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data…
REDWOOD CITY, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment…
EsoCap announces first patient enrolled in Phase II eosinophilic esophagitis trial
Randomized, placebo-controlled, double-blind Phase II trial to treat 42 patients ongoing in four European countries with ESO-101ESO-101, EsoCap’s lead product candidate, consists of a…